Literature DB >> 10591658

Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.

A T Nurden1, C Poujol, C Durrieu-Jais, P Nurden.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10591658     DOI: 10.1161/01.atv.19.12.2835

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  12 in total

Review 1.  Comparative pharmacology of GP IIb/IIIa antagonists.

Authors:  Karsten Schrör; Artur-Aron Weber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

Review 2.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

3.  The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used.

Authors:  Katriina Aalto-Setälä; Pekka J Karhunen; Jussi Mikkelsson; Kari Niemelä
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 4.  [Haemostaseology].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

5.  Pharmacokinetic and pharmacodynamic properties of batifiban coadministered with antithrombin agents in Chinese healthy volunteers.

Authors:  Xiao-Meng He; Ying Zhou; Jie Li; San-Lan Wu; Meng-Meng Jia; Ming-Zhou Liu; Hui Chen; Ke Chen; Sheng-Feng Li; Yao-Hua Wang; Wei-Yong Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10

6.  Lytic resistance of fibrin containing red blood cells.

Authors:  Nikolett Wohner; Péter Sótonyi; Raymund Machovich; László Szabó; Kiril Tenekedjiev; Marta M C G Silva; Colin Longstaff; Krasimir Kolev
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-07       Impact factor: 8.311

7.  Hirudins of the Asian medicinal leech, Hirudinaria manillensis: same same, but different.

Authors:  Phil Lukas; Robert Wolf; Bernhard H Rauch; Jan-Peter Hildebrandt; Christian Müller
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

8.  Review of Currently Available GP IIb/IIIa Inhibitors and Their Role in Peripheral Vascular Interventions.

Authors:  P Anondo Stangl; Sara Lewis
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

9.  Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.

Authors:  Marzenna Zielinska; Krzysztof Kaczmarek
Journal:  J Thromb Thrombolysis       Date:  2008-05-04       Impact factor: 2.300

10.  Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.

Authors:  Yihua Wu; Yu Shi; Han Wu; Chang Bian; Qian Tang; Geng Xu; Jun Yang
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.